High-dose vitamin D(3) supplementation in relapsing-remitting multiple sclerosis: a randomised clinical trial

BACKGROUND: Vitamin D insufficiency is associated with risk of multiple sclerosis (MS) relapse; whether supplementation influences prognosis is unknown. The Vitamin D to Ameliorate MS (VIDAMS) trial aimed to determine if high dose (5000 International Units (IU)/day) versus low dose (600 IU/day) vita...

Descripción completa

Detalles Bibliográficos
Autores principales: Cassard, Sandra D., Fitzgerald, Kathryn C., Qian, Peiqing, Emrich, Susan A., Azevedo, Christina J., Goodman, Andrew D., Sugar, Elizabeth A., Pelletier, Daniel, Waubant, Emmanuelle, Mowry, Ellen M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10130605/
https://www.ncbi.nlm.nih.gov/pubmed/37125397
http://dx.doi.org/10.1016/j.eclinm.2023.101957

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10130605/
https://www.ncbi.nlm.nih.gov/pubmed/37125397
http://dx.doi.org/10.1016/j.eclinm.2023.101957

Ejemplares similares